BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Vitamin E
,
rs2230926
,
BRAF
,
G-protein-coupled receptor binding
,
Arthritis
,
Lymphocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
3H thymidine
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
PBMCs of myelopathy/tropical spastic paraparesis patients treated with Fas agonist/antagonist mAbs
Mammary glands from cows, response to frequent milking during lactation
Explore Curated Studies Results
Literature
Most Relevant Literature
Alendronate and omeprazole in combination reduce angiogenic and growth signals from osteoblasts.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Diagnostic Immunization With Rabies Vaccine in Patients With PID
Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults
Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ